Effects of Maximally Tolerated Oral Therapy on the Six-Minute Walking Test in Patients With Chronic Congestive Heart Failure Secondary to Either Ischemic or Idiopathic Dilated Cardiomyopathy

This publication has 12 references indexed in Scilit:

• Effects of exercise training and activity restriction on 6-minute walking test performance in patients with chronic heart failure
  American Heart Journal, 1997
• Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
  Circulation, 1996
• The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure
  Chest, 1996
• Using exercise endpoints in heart failure trials: design considerations
  European Heart Journal, 1996
• What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
  European Heart Journal, 1996
• Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
  Journal of the American College of Cardiology, 1994
• Maximal exercise tolerance as a therapeutic end point in heart failure — Are we relying on the right measure?
  The American Journal of Cardiology, 1994
• Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction
  JAMA, 1993
• Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy
  The American Journal of Cardiology, 1990
• Six minute walking test for assessing exercise capacity in chronic heart failure.
  BMJ, 1986